Objectives:

1.  BMPR2 mutation is linked to PAH pathology. 

2.  Inflammation is central to PAH pathogenesis.

3.  iPSC-derived endothelial cells can be used to screen new PAH therapies.

 

Session date: 
Friday, September 8, 2017 - 12:00pm to 1:00pm
Location: 
UCMC
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.